Answers are grounded in this paper and cite their sources.
Approximately 10% of infantile hemangioma (IH) patients exhibit a suboptimal response to propranolol (PRN) therapy, necessitating alternative strategies to enhance its therapeutic efficacy. Female BALB/c nude mice were used to establish a xenograft model of IH and randomized into four groups (Saline, OMT alone, PRN alone, and PRN/OMT combination). EOMA cells were used as an in vitro IH model. Key proteins mediating the synergistic effect of the PRN/OMT combination were identified via proteomic analysis, followed by experimental validation. Compared with PRN alone, the combination of PRN/OMT induced a more pronounced antitumor effect in IH mice. In EOMA cells, OMT markedly decreased the IC50 of PRN. Moreover, the combination of PRN/OMT induced more severe mitochondrial damage, leading to a higher proportion of apoptotic cells. Furthermore, proteomic analysis identified AMBRA1 as one of the key differentially expressed proteins (DEPs) associated with PINK1/PRKN-mediated mitophagy that may contribute to the synergistic effect of the PRN/OMT combination. Notably, the synergistic effect of the PRN/OMT combination was significantly abrogated by either AMBRA1 knockdown or pretreatment with Mdivi-1 (a mitochondrial fission inhibitor). Mechanistically, aberrant AMBRA1 expression was regulated by PRN and OMT through distinct mechanisms: PRN was involved in the transcriptional activation of AMBRA1, whereas OMT was responsible for promoting AMBRA1 protein translation. This study revealed a synergistic effect of the PRN/OMT combination on hemangiomas, which could enhance the therapeutic efficacy of PRN therapy by inducing excessive mitophagy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: